drugset / Trial / NCT01425320

Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne

NCT01425320

Phase 1 Withdrawn Allergan
RandomizedParallel-groupTriple-blind

Summary

This study will investigate the pharmacokinetics, safety and tolerability of dapsone and adapalene following topical administration of 2 formulations of dapsone/adapalene fixed combination gel, dapsone 5% gel (ACZONE®), and adapalene 0.3% gel (Differin®) in subjects with acne vulgaris.

Timeline

Start
2013-01
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Adapalene Other / unclassified 0.3 % Topical
Comparator Dapsone Small molecule 5 % Topical

Indications